Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2007
12/19/2007CN101088496A Microecological bifid bacterium signal molecule prepn and its prepn process
12/19/2007CN101088495A Carrageenan capsule
12/19/2007CN101088494A Enteric coated granule and method for preparing the same
12/19/2007CN101088493A Nanometer alprosadil particle and its prepn process
12/19/2007CN101088492A Stable supersaturated gemcitabine hydrochloride solution and its prepn process
12/19/2007CN101088491A Anticancer composition
12/19/2007CN100355803C Use of an amorphous polyester as a polymer base for masticatory substances
12/19/2007CN100355744C Separation and extraction of flavone natural product active component for treating prostating disorders and medicinal preparation preparing and use thereof
12/19/2007CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof
12/19/2007CN100355553C Device and method for the production of three-dimensional objects
12/19/2007CN100355457C Dispersible pharmaceutical compositions
12/19/2007CN100355456C Calcium alginate/poly arginine-chitin glycan composite medicine release -controlled microcap sule and preparing method thereof
12/19/2007CN100355455C Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
12/19/2007CN100355454C Nano-magnetic powder antihuman lirer cancer single anti HAb18 target medicine for magnetic heat therapy
12/19/2007CN100355448C Chinese traditional medicine compound preparation for preventing and curing alcoholic intestinal tract and liver injury
12/19/2007CN100355442C Medicinal composition for treating diabets, and its prepn. method
12/19/2007CN100355439C Capsule for curing enteritis and bloody flux
12/19/2007CN100355432C Chinese and western compounded drug for treating alveolysis and its preparing method
12/19/2007CN100355430C Tibetan medicine for treating eye diseases, and its preparing method
12/19/2007CN100355429C Application of drynaria in the treatment of hyperthyroidism and its preparation
12/19/2007CN100355425C Stable granulates containing S-adenosylmethionine and process for the preparation thereof
12/19/2007CN100355422C Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
12/19/2007CN100355418C Magnetic nano-balls carried with cisplatin and its prepn. method
12/19/2007CN100355417C Formulation of 'Duyiwei' with improved bioavailability and drug effect and preparation process thereof
12/19/2007CN100355416C Cassia twig and poria cocos disperse tablet and its producing method
12/19/2007CN100355415C Frozen dry powder injection of astrogalus root and its preparing method
12/19/2007CA2820023A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
12/19/2007CA2602273A1 Composition and method for weight loss
12/19/2007CA2549115A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
12/18/2007US7309782 Pure crystalline azithromycin monohydrate hemi-ethanol solvate; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of mammals, birds and fish; drug resistance .
12/18/2007US7309719 Stabilized pharmaceutical preparation of gamma-aminobutyric acid derivatives and process for preparing the same
12/18/2007US7309707 Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
12/18/2007US7309698 Compositions for delivering bisphosphonates
12/18/2007US7309697 Cyclic maltosylmatose
12/18/2007US7309692 Inhibition of Grb2 and Crk1 gene products that interact with the bcr-abl product and participate in the transformation of Chronic myeloid leukemia
12/18/2007US7309689 Sustained peptide-release formulation
12/18/2007US7309688 Topical application of formulation containing non-denatured, soy product in a carrier for inhibiting the progression of a cutaneous tumor
12/18/2007US7309582 Polymer-template complex produced by enzymatic polymerization
12/18/2007US7309502 Pharmaceutical compositions for treating and saving and the method for the preparation thereof
12/18/2007US7309500 Microparticles
12/18/2007US7309499 Mixture of pectin and glycerin; stabilization with calcium gluconate, sucrose fatty acid ester, acetic acid; molding; cooling in air
12/18/2007US7309498 Biodegradable absorbents and methods of preparation
12/18/2007US7309497 Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients
12/18/2007CA2602189A1 Fat .beta.-oxidation enhancing and carbohydrate absorption inhibition
12/18/2007CA2436799C Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
12/18/2007CA2378436C Method for producing antibiotic composites
12/18/2007CA2311754C A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0.5 ml
12/18/2007CA2280130C Lyophilized compositions containing sphingoglycolipid and process for preparing them
12/18/2007CA2277377C Controlled release composition
12/18/2007CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/18/2007CA2219070C Methods of preventing breast cancer
12/18/2007CA2210076C Enrofloxacin injection or infusion solutions
12/18/2007CA2209001C Hydrophobic taxane derivatives
12/18/2007CA2103306C Extrudable compositions for topical or transdermal drug delivery
12/16/2007CA2550398A1 Mir-a-collar
12/15/2007CA2591350A1 Antacid and breath freshening composition
12/13/2007WO2007143652A2 Chewable soft gelatin capsules
12/13/2007WO2007143607A2 Method of treating atrophic vaginitis
12/13/2007WO2007143411A2 Use of a botulinum toxin for treating a urethral stricture
12/13/2007WO2007143410A2 Use of a botulinum toxin for treating a urethral stricture
12/13/2007WO2007143390A1 Nanoparticulate posaconazole formulations
12/13/2007WO2007143382A2 Oral liquid loratadine formulations and methods
12/13/2007WO2007143381A2 Microparticles and methods for production thereof
12/13/2007WO2007143331A2 Low irritation antimicrobial cleaning substrate
12/13/2007WO2007143290A2 Delayed-release compositions of extended release forms of venlafaxine
12/13/2007WO2007143185A2 Transdermal treatment of tendinopathy using glyceryl trinitrite
12/13/2007WO2007143163A2 Pharmaceutical compositions for sustained release of phenyephrine
12/13/2007WO2007143156A1 Phenylphrine pulsed release formulations and pharmaceutical compositions
12/13/2007WO2007143061A2 Prednisolone salt formulations
12/13/2007WO2007142942A2 Method of improving wound healing
12/13/2007WO2007142781A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
12/13/2007WO2007142628A1 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
12/13/2007WO2007142548A2 Vesicular formulations containing organic acid prodrugs, process for their preparation
12/13/2007WO2007142546A2 Sustained release coated tablet with precisely regulated release profile
12/13/2007WO2007142510A1 Modulation of the immune system by inositol phospholipids
12/13/2007WO2007142440A1 Stable pharmaceutical composition containing paclitaxel and a method of manufacturing the same
12/13/2007WO2007142295A1 Novel tape preparation
12/13/2007WO2007142280A1 Hydrogel sheet and production method thereof
12/13/2007WO2007142259A1 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2h-pyridazine-3-one-containing complex and process for producing the same
12/13/2007WO2007142212A1 Preparation composition
12/13/2007WO2007141807A2 A synergistic herbal composition from bacopa species for management of neurodegenerative disorders and a process of preparation thereof
12/13/2007WO2007141806A1 Pharmaceutical formulations comprising oxcarbazepine and methods thereof
12/13/2007WO2007141743A2 A tablet dosage form comprising cetirizine and pseudoephedrine
12/13/2007WO2007141694A1 Device for the controlled release of a substance
12/13/2007WO2007141667A2 Immunosuppressive extract of cordyceps sinensis and uses thereof
12/13/2007WO2007141590A1 Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis
12/13/2007WO2007141344A2 Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
12/13/2007WO2007141328A1 Low dose sublingual tablets of opioid analgesics and preparation process
12/13/2007WO2007141308A1 Process for preparing spray dried formulations of tmc125
12/13/2007WO2007141298A1 Stabilized pharmaceutical compositions comprising fesoterodine
12/13/2007WO2007141282A2 Process for making multiparticulates using a roller compactor
12/13/2007WO2007141182A2 Utilization of vinyl acetate sulfonate copolymers as solubilizers for compounds with low solubility in water
12/13/2007WO2007141050A2 Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications
12/13/2007WO2007140909A1 Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient flux
12/13/2007WO2007140622A1 Dairy-derived probiotic compositions and uses thereof
12/13/2007WO2007140621A1 Probiotic compositions and uses thereof
12/13/2007WO2007140614A1 Nasal formulation
12/13/2007WO2007140613A1 Fermented milk product and use thereof
12/13/2007WO2007140588A1 Pathogenic attenuation via the administration of an equilibiotic compound
12/13/2007WO2007140510A1 Agrochemical composition comprising liquid crystal particles
1 ... 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 ... 2991